In patients with AMI who have recovered from their CS, the presence of AKI precludes the use of guideline-directed medical therapy such as angiotensin-converting enzyme-inhibitors, angiotensin receptor blockers, and aldosterone inhibitors [94]. Here, ACE is linked to acute kidney injury.